Correction: Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways (PLoS One (2013) 8:5 (e61747) DOI: 10.1371/journal.pone.0061747);Crosstalk from Non-Cancerous Mitochondria Can Inhibit Tumor Properties of Metastatic Cells by Suppressing Oncogenic Pathways

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Kaipparettu, Benny Abraham ^a   Ma, Yewei ^a   Park, Jun Hyoung ^a   Lee, Tin Lap ^b,c   Zhang, Yiqun ^a   Yotnda, Patricia ^a   Creighton, Chad J ^a   Chan, Wai Yee ^b,c   Wong, Lee Jun C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BREAST CANCER; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MITOCHONDRION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OSTEOSARCOMA CELL; OXYGEN CONSUMPTION; RESPIRATORY CHAIN; TUMOR GROWTH;

EID: 84877317238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0221671     Document Type: Erratum

References (42)

1. Warburg O, (1956) On the origin of cancer cells. Science 123: 309-314.
2. Gatenby RA, Gillies RJ, (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899.
3. Ma Y, Bai RK, Trieu R, Wong LJ, (2010) Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids. Biochim Biophys Acta 1797: 29-37.
4. Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, et al. (2005) Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65: 1655-1663.
5. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, et al. (2005) mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A 102: 719-724.
6. Kaipparettu BA, Ma Y, Wong LJ, (2010) Functional effects of cancer mitochondria on energy metabolism and tumorigenesis: utility of transmitochondrial cybrids. Ann N Y Acad Sci 1201: 137-146.
7. King MP, Attardi G, (1989) Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246: 500-503.
8. Vithayathil SA, Ma Y, Kaipparettu BA, (2012) Transmitochondrial cybrids: tools for functional studies of mutant mitochondria. Methods Mol Biol 837: 219-230.
9. Tu YF, Kaipparettu BA, Ma Y, Wong LJ, (2011) Mitochondria of highly metastatic breast cancer cell line MDA-MB-231 exhibits increased autophagic properties. Biochim Biophys Acta 1807: 1125-1132.
10. Kulawiec M, Owens KM, Singh KK, (2009) mtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice. J Hum Genet 54: 647-654.
11. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, et al. (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320: 661-664.
12. Bayona-Bafaluy MP, Manfredi G, Moraes CT, (2003) A chemical enucleation method for the transfer of mitochondrial DNA to rho(o) cells. Nucleic Acids Res 31: e98.
13. Tan DJ, Bai RK, Wong LJ, (2002) Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62: 972-976.
14. Wang J, Brautbar A, Chan AK, Dzwiniel T, Li FY, et al. (2009) Two mtDNA mutations 14487T>C (M63V, ND6) and 12297T>C (tRNA Leu) in a Leigh syndrome family. Mol Genet Metab 96: 59-65.
15. Ware SM, El-Hassan N, Kahler SG, Zhang Q, Ma YW, et al. (2009) Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes. J Med Genet 46: 308-314.
16. Dimmock D, Tang LY, Schmitt ES, Wong LJ, (2010) Quantitative evaluation of the mitochondrial DNA depletion syndrome. Clin Chem 56: 1119-1127.
17. Venegas V, Wang J, Dimmock D, Wong LJ (2011) Real-time quantitative PCR analysis of mitochondrial DNA content. Curr Protoc Hum Genet Chapter 19: Unit 19 17.
18. McLennan HR, Degli Esposti M, (2000) The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J Bioenerg Biomembr 32: 153-162.
19. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, et al. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15: 961-973.
20. Chen X, Tian Y, Yao L, Zhang J, Liu Y, (2009) Hypoxia stimulates proliferation of rat neural stem cells with influence on the expression of cyclin D1 and c-Jun N-terminal protein kinase signaling pathway in vitro. Neuroscience 165: 705-714.
21. Berridge MV, Tan AS, McCoy KD, Kansara M, Rudert F, (1996) CD95 (Fas/Apo-1)-induced apoptosis results in loss of glucose transporter function. J Immunol 156: 4092-4099.
22. Ghelli A, Zanna C, Porcelli AM, Schapira AH, Martinuzzi A, et al. (2003) Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium. J Biol Chem 278: 4145-4150.
23. Ohta H, Aoyagi K, Fukaya M, Danjoh I, Ohta A, et al. (2009) Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers. Br J Cancer 100: 389-398.
24. Creighton CJ, (2008) Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors. PLoS One 3: e1816.
25. Dasgupta S, Hoque MO, Upadhyay S, Sidransky D, (2008) Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res 68: 700-706.
26. Garber K, (2006) Energy deregulation: licensing tumors to grow. Science 312: 1158-1159.
27. Modica-Napolitano JS, Kulawiec M, Singh KK, (2007) Mitochondria and human cancer. Curr Mol Med 7: 121-131.
28. Minocherhomji S, Tollefsbol TO, Singh KK, (2012) Mitochondrial regulation of epigenetics and its role in human diseases. Epigenetics 7: 326-334.
29. Shock LS, Thakkar PV, Peterson EJ, Moran RG, Taylor SM, (2011) DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc Natl Acad Sci U S A 108: 3630-3635.
30. Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, et al. (2001) High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 61: 5998-6001.
31. Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, et al. (2001) High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer 93: 534-538.
32. Tan DJ, Chang J, Chen WL, Agress LJ, Yeh KT, et al. (2003) Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers. Genes Chromosomes Cancer 37: 186-194.
33. Zhang J, Kamdar O, Le W, Rosen GD, Upadhyay D, (2009) Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am J Respir Cell Mol Biol 40: 135-146.
34. Yen HC, Tang YC, Chen FY, Chen SW, Majima HJ, (2005) Enhancement of cisplatin-induced apoptosis and caspase 3 activation by depletion of mitochondrial DNA in a human osteosarcoma cell line. Ann N Y Acad Sci 1042: 516-522.
35. Yamazaki H, Yoshida K, Yoshioka Y, Isohashi F, Ozeki S, et al. (2008) Impact of mitochondrial DNA on hypoxic radiation sensitivity in human fibroblast cells and osteosarcoma cell lines. Oncol Rep 19: 1545-1549.
36. Augenlicht LH, Heerdt BG, (2001) Mitochondria: integrators in tumorigenesis? Nat Genet 28: 104-105.
37. Davids MS, Letai A, (2012) Targeting the B-cell lymphoma/leukemia 2 family in cancer. J Clin Oncol 30: 3127-3135.
38. Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, et al. (2011) Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 334: 1129-1133.
39. Neuzil J, Dyason JC, Freeman R, Dong LF, Prochazka L, et al. (2007) Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. J Bioenerg Biomembr 39: 65-72.
40. Biasutto L, Dong LF, Zoratti M, Neuzil J, (2010) Mitochondrially targeted anti-cancer agents. Mitochondrion 10: 670-681.
41. Dong LF, Swettenham E, Eliasson J, Wang XF, Gold M, et al. (2007) Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Cancer Res 67: 11906-11913.
42. Neuzil J, Dong LF, Rohlena J, Truksa J, Ralph SJ, (2012) Classification of mitocans, anti-cancer drugs acting on mitochondria. Mitochondrion 13: 199-208.